SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019694
Filing Date
2020-04-29
Accepted
2020-04-29 16:02:32
Documents
7
Period of Report
2020-06-09
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A sndx-def14a_20200430.htm DEF 14A 1023709
2 GRAPHIC gtetgsvaiasj000006.jpg GRAPHIC 69991
3 GRAPHIC gtetgsvaiasj000003.jpg GRAPHIC 2919
4 GRAPHIC gtetgsvaiasj000004.jpg GRAPHIC 1659
5 GRAPHIC gtetgsvaiasj000002.jpg GRAPHIC 1377
6 GRAPHIC gtetgsvaiasj000005.jpg GRAPHIC 82938
7 GRAPHIC gtetgsvaiasj000001.jpg GRAPHIC 2892
  Complete submission text file 0001564590-20-019694.txt   1248442
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37708 | Film No.: 20830166
SIC: 2834 Pharmaceutical Preparations